Jonas Brambeck
Board member
Medical Science
Oncopeptides
Sweden
Biography
Jonas Brambeck was appointed to the board of Oncopeptides in 2008. In addition to being a board member of Oncopeptides, Jonas is an Investment Manager at Industrifonden, a leading Nordic venture capital fund, and a member of the Board of Directors of the life sciences companies Oxthera AB, Cardoz AB and Nuevolution AS. He has previously held positions at a number of life sciences businesses including AstraZeneca, Bruker Instruments and Nobel. Jonas holds a PhD in organic chemistry from The Royal Institute of Technology in Stockholm. Born: 1958 Board Committees: Chairman of the Audit Committee and Member of the Remuneration Committee Holdings in Oncopeptides: Nil Other current positions: Athera Biotechnologies AB, CMC Contrast AB, OxThera AB and OxThera Intellectual Property AB. Independent in relation to the Company and its senior management, but not in relation to major shareholders. Employee of Industrifonden Foundation (Stiftelsen Industrifonden).
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
